Stock listing
MAZE Stock Price, News, Filings & Events — Maze Therapeutics, Inc.
Selected listing: MAZE · BOATS · USD · US
This page tracks Maze Therapeutics, Inc.'s MAZE:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MAZE:BOATS. MAZE:BOATS is the stock-level entry point for investors researching Maze Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maze Therapeutics, Inc. is a public company listed under the ticker MAZE, operating in the American market. The company has a market capitalization of approximately $1.53 billion. Maze Therapeutics focuses on developing innovative therapies to address genetic diseases.

- Ticker
- MAZE:BOATS
- Asset type
- Stock
- Market cap
- $1.52B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Maze Therapeutics, Inc. MAZE:BOATS stock context
This page tracks Maze Therapeutics, Inc.'s MAZE:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MAZE:BOATS. MAZE:BOATS is the stock-level entry point for investors researching Maze Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Maze Therapeutics, Inc. is a public company listed under the ticker MAZE, operating in the American market. The company has a market capitalization of approximately $1.53 billion. Maze Therapeutics focuses on developing innovative therapies to address genetic diseases.
Latest news from Maze Therapeutics, Inc.
Maze Therapeutics Announces Appointments to Its Board of Directors
August 13, 2026
Maze Therapeutics Announces $150 Million Registered Offering
April 22, 2026
Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept ...
March 25, 2026
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
March 25, 2026
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
February 25, 2026
Maze Therapeutics, Inc. earnings calls
Research Maze Therapeutics, Inc.
Maze Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for MAZE:BOATS.
Maze Therapeutics, Inc. company profile
View the public company page for Maze Therapeutics, Inc. on 6ix.
Maze Therapeutics, Inc. news
Read company news and market updates connected to Maze Therapeutics, Inc..
Maze Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Maze Therapeutics, Inc..